Promising approach

MyJourneywithCancer

Posts: 83
Joined: May 2017

Nov 15, 2017 - 2:48 pm

As I am waiting to read the full text, I would like to share this:
Next Generation Sequencing (NGS) is becoming a reliable approach for molecular profiling and treatment decision for non-small cell lung cancer (NSCLC) patients. At least one genetic alteration was found in 78% of the patients. 23% patients showed mutations for which approved (ALK, EGFR, ROS1) or emerging (BRAF, ERBB2, MET, RET) targeted therapies exist.
The details are here: https://www.ncbi.nlm.nih.gov/pubmed/29130105

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

CSN

cancer.org

You are here

Promising approach